University of Trento

Helmsley Charitable Trust Awards Over $12 Million to Projects Aimed at Helping People With Type 1 Diabetes Safely Incorporate Exercise Into Their Daily Lives

Retrieved on: 
Tuesday, February 13, 2024

Today, The Leona M. and Harry B. Helmsley Charitable Trust announces seven new grants to support research aimed at helping people with type 1 diabetes (T1D) more safely incorporate exercise into their lives.

Key Points: 
  • Today, The Leona M. and Harry B. Helmsley Charitable Trust announces seven new grants to support research aimed at helping people with type 1 diabetes (T1D) more safely incorporate exercise into their lives.
  • More research and solutions are urgently needed to ease the burden of exercise with T1D management.
  • The data sets are publicly available through Vivli, a data-sharing platform that hosts information on a variety of health conditions.
  • The study will provide practical advice and a potentially cost-effective solution for people with T1D engaging in exercise.

COSBI and InSilicoTrials Announce Strategic Partnership to Revolutionize Drug Development and Regulatory Approval

Retrieved on: 
Tuesday, June 27, 2023

Under this strategic partnership, COSBI will provide InSilicoTrials with its unique computational models and simulation tools, leveraging their expertise in systems biology and computational biology.

Key Points: 
  • Under this strategic partnership, COSBI will provide InSilicoTrials with its unique computational models and simulation tools, leveraging their expertise in systems biology and computational biology.
  • Enrico Domenici, CEO of COSBI, expressed his enthusiasm about the collaboration, stating, "The strategic partnership with InSilicoTrials represents a crucial step toward advancing personalized medicine and nutrition.
  • By integrating our computational models into their simulation platform, we can significantly improve decision-making, reduce costs, and accelerate the regulatory processes involved in drug development."
  • By incorporating COSBI's advanced computational models and simulation tools, we can significantly enhance the efficiency and effectiveness of the drug development and regulatory approval processes."

COSBI and InSilicoTrials Announce Strategic Partnership to Revolutionize Drug Development and Regulatory Approval

Retrieved on: 
Tuesday, June 27, 2023

Under this strategic partnership, COSBI will provide InSilicoTrials with its unique computational models and simulation tools, leveraging their expertise in systems biology and computational biology.

Key Points: 
  • Under this strategic partnership, COSBI will provide InSilicoTrials with its unique computational models and simulation tools, leveraging their expertise in systems biology and computational biology.
  • Enrico Domenici, CEO of COSBI, expressed his enthusiasm about the collaboration, stating, "The strategic partnership with InSilicoTrials represents a crucial step toward advancing personalized medicine and nutrition.
  • By integrating our computational models into their simulation platform, we can significantly improve decision-making, reduce costs, and accelerate the regulatory processes involved in drug development."
  • By incorporating COSBI's advanced computational models and simulation tools, we can significantly enhance the efficiency and effectiveness of the drug development and regulatory approval processes."

Slow Down, Connect and Share Stories with Scholastic, LitWorld®, and Fan-Favorite Children's Authors to Celebrate World Read Aloud Day® on February 1st

Retrieved on: 
Monday, January 23, 2023

NEW YORK, Jan. 23, 2023 /PRNewswire/ -- With families busier than ever, LitWorld®, the global non-profit advocating for the power of sharing stories and founder of World Read Aloud Day, and Scholastic, the global children's publishing, education and media company, are encouraging communities across the globe to slow down and connect through reading on February 1, 2023, for World Read Aloud Day (WRAD). Celebrated on the ground in 173 countries, the 14th annual celebration is going truly global with free, virtual programming spanning across time zones for 24 hours. Internationally, children's book authors will be reading aloud and sharing pre-recorded messages from 13 countries through Storyvoice, a digital app where each week 1,000s of children, classrooms and families read and interact live with Scholastic authors.

Key Points: 
  • Internationally, children's book authors will be reading aloud and sharing pre-recorded messages from 13 countries through Storyvoice, a digital app where each week 1,000s of children, classrooms and families read and interact live with Scholastic authors.
  • To access additional resources from LitWorld®, the founder of World Read Aloud Day, including activity guides, book lists, and printable bookmarks, visit: www.litworld.org/worldreadaloudday .
  • I hope you will join me in celebrating and supporting the power of story-telling on this day and throughout the year."
  • For more information about LitWorld®, visit: https://litworld.org
    For more information about Scholastic (NASDAQ: SCHL), visit the Company's media room: http://mediaroom.scholastic.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/slow-down-connect-and-share-sto...

Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform

Retrieved on: 
Tuesday, October 4, 2022

We have gained the support of a strong group of expert investors and the capital to advance our small molecule pipeline, expand our protein folding simulation technology platform and bring additional expertise to our team.

Key Points: 
  • We have gained the support of a strong group of expert investors and the capital to advance our small molecule pipeline, expand our protein folding simulation technology platform and bring additional expertise to our team.
  • Sibylla is disrupting the protein degradation landscape by applying a novel mechanism of action that interferes with protein folding and thereby suppresses the expression of a disease-relevant protein.
  • Through their protein folding simulation technology platform, Sibylla identifies relevant and previously inexplorable folding intermediates for protein targets that are currently considered undruggable in their native state.
  • Vertis SGR funded the breakthrough discovery technology resulting from the collaboration, enabling the initial validation of Sibyllas technology.

Trento, Data Confirmed the Success of the Festival

Retrieved on: 
Monday, June 6, 2022

TRENTO, Italy, June 06, 2022 (GLOBE NEWSWIRE) -- The 17th edition of the Trento Festival of Economics closed yesterday.

Key Points: 
  • TRENTO, Italy, June 06, 2022 (GLOBE NEWSWIRE) -- The 17th edition of the Trento Festival of Economics closed yesterday.
  • The data confirm the success of the new formula, especially the high participation, both by the public and by the over 600 speakers, 35% of them women, in the 228 events scheduled in the Festival, "Fuori Festival" (new 2022), "Economies of the territories", "Meetings with the Author" and the live events on Radio 24.
  • The entertainment programme of the Fuori Festival was also a great success, with the two classical music concerts, the encounter with Mahmood, the evening event with Zelig comedians and the five live Radio 24 shows sold out.
  • 369 journalists were accredited this year and 249 of them were present in Trento, with reporters from the most important national newspapers and 10,000 photo shoots.

Great Start for the Festival of Economics in Trento

Retrieved on: 
Thursday, June 2, 2022

TRENTO, Italy, June 02, 2022 (GLOBE NEWSWIRE) -- Festive atmosphere during the Festival of Economics, which started this morning with great participation, especially among young people.

Key Points: 
  • TRENTO, Italy, June 02, 2022 (GLOBE NEWSWIRE) -- Festive atmosphere during the Festival of Economics, which started this morning with great participation, especially among young people.
  • Organised by the Autonomous Province of Trento, through Trentino Marketing and the Gruppo 24 ORE in collaboration with the University of Trento and the Municipality of Trento, the Trento Festival of Economics is now in its 17th edition.
  • And then at the Sala della Cooperazione for the meeting 'Art 45, Constitution and Cooperatives: an indissoluble bond', the Filarmonica where many people listened to Giovanni Tria.
  • In the afternoon, the Opening Ceremony of the event was held, opened by the dialogue between writer Silvia Avallone and Cardinal Gianfranco Ravasi, President of the Pontifical Council for Culture, who then gave the speech For a new philosophy of development, between ethics and spirituality.

ZOE Study Finds Novel Link Between Menopause and Metabolic Health

Retrieved on: 
Tuesday, March 22, 2022

BOSTON, March 22, 2022 /PRNewswire/ -- Researchers from personalized nutrition company ZOE and world-leading scientists from King's College London, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital, have revealed that diet can be the key to reducing unfavorable health changes associated with menopause. This is according to the largest study of its kind, published as a pre-print in The Lancet, which explores how menopause affects day-to-day metabolism.

Key Points: 
  • Chan School of Public Health, and Massachusetts General Hospital, have revealed that diet can be the key to reducing unfavorable health changes associated with menopause.
  • Our research shows that menopause is a time of major metabolic upheaval, which can have significant impact on long-term health.
  • These findings will help us deliver simple yet more personalized nutrition and health advice with greater efficacy to reduce the health burden of menopause."
  • ZOE runs the largest nutrition-science study in the world to understand the complex relationship between food and health.